Drug intelligence / Profile preview

Huangqi Guizhi Wuwu Tang

Development stage
Unknown
Lead developer
China Medical University Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Huangqi Guizhi Wuwu Tang (HQGZWWT) is a traditional Chinese herbal formula composed of five primary ingredients: *Astragalus membranaceus*, *Paeonia lactiflora*, *Cinnamomum cassia* (twigs), *Zingiber officinale*, and *Ziziphus jujuba*. Historically used to treat 'blood bi' syndrome and hemiplegia, it is currently being evaluated for its efficacy in improving cerebral hemodynamics in patients with intracranial arterial stenosis (IAPS). The formula's therapeutic effects are attributed to active compounds such as astragaloside IV and paeoniflorin, which have demonstrated neuroprotective properties and the ability to reduce cerebral infarction size in preclinical models. In clinical settings, it is often administered as granules to prevent the progression of arterial stenosis and reduce the incidence of stroke.

Other names
Huang-Chi-Wu-Wu-TangAstragalus and Cinnamon Five-Herb DecoctionHQGZWWT
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)ESR1 (ERα)HIF1A (Hypoxia-inducible factor 1-alpha)MAPK3 (Mitogen-activated protein kinase 1)PDE5 (Phosphodiesterase 5A)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TGFB (GARP–latent transforming growth factor beta 1 complex)

Beyond the preview

Go deeper on Huangqi Guizhi Wuwu Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangqi Guizhi Wuwu Tang.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call